Literature DB >> 1341323

The incidence of HPV in a Swedish series of invasive cervical carcinoma.

B Hagmar1, B Johansson, M Kalantari, Z Petersson, B Skyldberg, L Walaas.   

Abstract

The incidence of HPV was studied in 71 invasive squamous carcinomas of the cervix using PCR technique. We used primers, which presumably recognize all types of HPV (consensus primers), and also type-specific primers. In situ hybridization was carried out in 24 of the cases. The overall incidence of HPV was 53/71 (75%) of which 5 cases were positive with the consensus primers only. However, 21/71 cases (30%) were negative for the consensus primers but positive for one of the type-specific primer pairs. This finding indicates that subgenomic deletions may have occurred in the viral genome upon integration in the human DNA. In situ hybridization was positive in 14/24 cases (58%), showing excellent correlation with PCR results. The HPV types detected were, in descending order of frequency: type 16 (52%), 31 (23%), 18 (13%), 33 (12%). No cases of HPV type 6 or 11 were found in this series of invasive carcinomas.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1341323     DOI: 10.1007/bf02987743

Source DB:  PubMed          Journal:  Med Oncol Tumor Pharmacother        ISSN: 0736-0118


  17 in total

Review 1.  Epidemiology of human papillomavirus (HPV) infections and their associations with genital squamous cell cancer. Review article.

Authors:  K J Syrjänen
Journal:  APMIS       Date:  1989-11       Impact factor: 3.205

2.  In situ human papillomavirus (HPV) genotyping of cervical intraepithelial neoplasia in South African and British patients: evidence for putative HPV integration in vivo.

Authors:  K Cooper; C S Herrington; A K Graham; M F Evans; J O McGee
Journal:  J Clin Pathol       Date:  1991-05       Impact factor: 3.411

3.  Detection of human papillomavirus infection in tissue blocks by in situ hybridization as compared with a polymerase chain reaction procedure.

Authors:  B Skyldberg; M Kalantari; M Kärki; B Johansson; B Hagmar; L Walaas
Journal:  Hum Pathol       Date:  1991-06       Impact factor: 3.466

4.  PCR amplification from paraffin-embedded tissues: recommendations on fixatives for long-term storage and prospective studies.

Authors:  C E Greer; J K Lund; M M Manos
Journal:  PCR Methods Appl       Date:  1991-08

Review 5.  Association of human papillomavirus with gynecologic cancer.

Authors:  A T Lorincz; R Reid
Journal:  Curr Opin Oncol       Date:  1989-10       Impact factor: 3.645

6.  Differential early viral gene expression in two stages of human papillomavirus type 16 DNA-induced malignant transformation.

Authors:  S Yasumoto; J Doniger; J A DiPaolo
Journal:  Mol Cell Biol       Date:  1987-06       Impact factor: 4.272

7.  Sexually transmitted papillomaviral infections. I. The anatomic distribution and pathologic grade of neoplastic lesions associated with different viral types.

Authors:  R Reid; M Greenberg; A B Jenson; M Husain; J Willett; Y Daoud; G Temple; C R Stanhope; A I Sherman; G D Phibbs
Journal:  Am J Obstet Gynecol       Date:  1987-01       Impact factor: 8.661

Review 8.  Papillomaviruses in anogenital cancer as a model to understand the role of viruses in human cancers.

Authors:  H zur Hausen
Journal:  Cancer Res       Date:  1989-09-01       Impact factor: 12.701

Review 9.  Genital human papillomavirus infections.

Authors:  J M Douglas; B A Werness
Journal:  Clin Lab Med       Date:  1989-09       Impact factor: 1.935

10.  Human papillomavirus in dysplasia and carcinoma of the cervix in Singapore.

Authors:  S K Lim-Tan; H Yoshikawa; I T Sng; E M de Villiers; H zur Hausen; T H Ho; T Yoong
Journal:  Pathology       Date:  1988-10       Impact factor: 5.306

View more
  7 in total

1.  Cribriform adenocarcinoma of minor salivary glands may express galectin-3, cytokeratin 19, and HBME-1 and contains polymorphisms of RET and H-RAS proto-oncogenes.

Authors:  Jan Laco; Kateřina Kamarádová; Pavla Vítková; Eva Sehnálková; Sárka Dvořáková; Eliška Václavíková; Vlasta Sýkorová; Jana Kašpírková; Alena Skálová; Aleš Ryška
Journal:  Virchows Arch       Date:  2012-09-28       Impact factor: 4.064

2.  HPV-related Multiphenotypic Sinonasal Carcinoma: An Expanded Series of 49 Cases of the Tumor Formerly Known as HPV-related Carcinoma With Adenoid Cystic Carcinoma-like Features.

Authors:  Justin A Bishop; Simon Andreasen; Jen-Fan Hang; Martin J Bullock; Tiffany Y Chen; Alessandro Franchi; Joaquin J Garcia; Douglas R Gnepp; Carmen R Gomez-Fernandez; Stephan Ihrler; Ying-Ju Kuo; James S Lewis; Kelly R Magliocca; Stefan Pambuccian; Ann Sandison; Emmanuelle Uro-Coste; Edward Stelow; Katalin Kiss; William H Westra
Journal:  Am J Surg Pathol       Date:  2017-12       Impact factor: 6.394

3.  Use of multiple PCR primer sets for optimal detection of human papillomavirus.

Authors:  F Karlsen; M Kalantari; A Jenkins; E Pettersen; G Kristensen; R Holm; B Johansson; B Hagmar
Journal:  J Clin Microbiol       Date:  1996-09       Impact factor: 5.948

4.  Human papillomavirus-related carcinoma with adenoid cystic-like features: a peculiar variant of head and neck cancer restricted to the sinonasal tract.

Authors:  Justin A Bishop; Takenori Ogawa; Edward B Stelow; Christopher A Moskaluk; Wayne M Koch; Sara I Pai; William H Westra
Journal:  Am J Surg Pathol       Date:  2013-06       Impact factor: 6.394

5.  HPV typing of high-grade dysplasia (CIN III) in cone biopsies of 38 HPV-vaccinated women.

Authors:  Ondrej Ondič; Jana Kašpírková; Ondřej Májek; Iva Kinkorová
Journal:  Virchows Arch       Date:  2013-11-26       Impact factor: 4.064

6.  The retinoblastoma protein-associated cell cycle arrest in S-phase under moderate hypoxia is disrupted in cells expressing HPV18 E7 oncoprotein.

Authors:  O Amellem; J A Sandvik; T Stokke; E O Pettersen
Journal:  Br J Cancer       Date:  1998-03       Impact factor: 7.640

7.  A prospective study of the relationship between prediagnostic human papillomavirus seropositivity and HPV DNA in subsequent cervical carcinomas.

Authors:  E Sigstad; A K Lie; T Luostarinen; J Dillner; E Jellum; M Lehtinen; S Thoresen; V Abeler
Journal:  Br J Cancer       Date:  2002-07-15       Impact factor: 7.640

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.